Sevelamer HCL 800 MG tablet 180S
Ended Awarded
- Contract number
- SPE2DB25FEZG1
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $2,114
Award facts
- Contract value 100% obligated
- $2,113.89 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency (DLA) awarded a delivery order valued at $2,113.89 to AmerisourceBergen Drug Corp for the supply of Sevelamer HCL 800 mg tablets (180-count) on July 23, 2025, with completion expected by July 24, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.999 billion pharmaceutical prime vendor agreement running through December 2026 that supplies a comprehensive range of medications and medical commodities to support military healthcare systems globally.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, serves as a critical federal medical procurement vendor for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The company has established a substantial portfolio of delivery orders through its DLA prime contract, consistently fulfilling requirements for specialty medications, brand-name and generic pharmaceuticals, vaccines, and medical supplies across multiple therapeutic domains. This specific order for Sevelamer HCL—a phosphate binder medication used in renal disease management—reflects the company's role in supplying specialized pharmaceutical commodities necessary for military medical operations and veteran healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FEZG1?
SPE2DB25FEZG1 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on July 23, 2025.
How much is contract SPE2DB25FEZG1 worth?
The government has obligated $2,114 on SPE2DB25FEZG1.
Is contract SPE2DB25FEZG1 an order under another contract?
Yes. SPE2DB25FEZG1 is a delivery order under SPE2DB22D1106, an indefinite delivery contract.
Was contract SPE2DB25FEZG1 competed?
The extent of competition for SPE2DB25FEZG1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award